Literature DB >> 20939686

Challenges and opportunities in respiratory drug delivery devices.

Kurt Nikander.   

Abstract

Recent reviews conclude that there is a need to improve the management of respiratory diseases treated with inhaled drugs, mainly asthma and chronic obstructive pulmonary disease (COPD). Healthcare professionals - mainly in primary care - seem to lack to some degree the evidence-based information required for the selection of the most appropriate respiratory drug delivery devices (inhalers) for the patients, whereas some of the patients often tend to have poor inhaler technique. This could have an impact on the ability to control the respiratory diseases in question. There are probably several reasons for these apparent challenges in the primary care arena. Owing to the abundance of inhalers available at present, especially for the treatment of asthma and COPD, it is quite a challenge to pick the 'right' inhaler for each patient. For an inhaler to be optimal, the patient has to be able to master the inhaler technique required for the specific inhaler. The patient-inhaler interfaces - mouthpieces or facemasks - can add important challenges that further diminish the efficacy of the treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20939686     DOI: 10.1517/17425247.2010.525231

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  4 in total

1.  Inhaler devices for chronic obstructive pulmonary disease: insights from patients and healthcare practitioners.

Authors:  Mathieu Molimard; Paul Colthorpe
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2014-09-29       Impact factor: 2.849

Review 2.  Concepts of advanced therapeutic delivery systems for the management of remodeling and inflammation in airway diseases.

Authors:  Daljeet Singh Dhanjal; Parvarish Sharma; Meenu Mehta; Murtaza M Tambuwala; Parteek Prasher; Keshav R Paudel; Gang Liu; Shakti D Shukla; Philip M Hansbro; Dinesh Kumar Chellappan; Kamal Dua; Saurabh Satija
Journal:  Future Med Chem       Date:  2022-01-12       Impact factor: 3.808

Review 3.  Practical aspects of inhaler use in the management of chronic obstructive pulmonary disease in the primary care setting.

Authors:  Barbara P Yawn; Gene L Colice; Rick Hodder
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-07-25

4.  Is 'GOLD' standard for the management of COPD in clinical practice?

Authors:  Barbara P Yawn
Journal:  Drugs Context       Date:  2012-11-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.